Acer therapeutics inc. (ACER)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Operating expenses:
Option Revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,905

2,905

2,556

2,137

1,719

1,300

1,271

1,313

1,354

1,395

1,266

0

0

0

-

-

-

-

-

-

-

-

-

-

Research and development

12,227

13,851

16,333

15,882

14,324

12,452

8,916

8,595

7,765

8,725

10,224

6,556

6,513

5,308

4,595

8,626

9,231

10,039

10,202

10,955

11,944

12,118

12,236

11,557

10,370

9,181

8,153

7,114

6,449

6,318

5,650

4,848

4,144

3,340

2,819

2,949

0

0

0

General and administrative

14,464

16,046

17,070

16,266

11,575

9,261

8,305

7,878

6,806

5,223

2,517

940

737

1,391

2,870

4,168

4,239

4,258

3,899

3,793

3,736

3,833

4,178

3,887

3,671

3,670

3,110

3,015

2,794

2,508

2,546

2,599

2,630

2,406

2,364

2,375

0

0

0

Total operating expenses

26,691

29,897

33,404

32,149

25,899

21,713

17,221

16,473

14,572

13,948

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from operations

-26,691

-29,897

-33,404

-32,149

-25,899

-21,713

-17,221

-16,473

-14,572

-13,948

-14,055

-8,810

-7,904

-6,699

-5,500

-10,193

-10,893

-12,093

-12,337

-13,410

-14,769

-15,067

-15,472

-14,455

-13,001

-11,923

-10,684

-9,891

-9,342

-9,133

-8,484

-7,711

-7,033

-5,966

-5,379

-5,511

0

0

0

Other income, net:
Interest income (expense), net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

5

5

7

9

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

311

471

626

674

567

412

216

80

45

14

0

0

0

-

0

-

-

-

-

-

-

-

-

-

18

14

9

5

2

0

0

0

0

0

1

1

0

0

0

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Gain on derivative instruments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Interest expense

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

2,267

2,465

2,270

1,985

350

152

2

2

3

4

396

0

0

0

Loss on disposal of asset

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign currency transaction (loss) gain

-17

8

19

3

66

20

7

4

-39

-16

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other income, net

0

-

0

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

303

327

351

371

379

389

387

369

362

352

335

336

327

314

303

278

253

247

210

194

186

0

0

0

Loss on disposal of asset

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

0

-

-

0

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Total other income, net

-

-

-

676

-

-

-

-37

-226

-246

-243

-125

-14

0

39

50

59

68

36

24

13

2

0

0

0

37

0

0

0

-

-

-

-

-

-

-

-

-

-

Net loss

-26,397

-29,417

-32,757

-31,472

-25,265

-21,280

-16,998

-16,511

-14,798

-14,194

-10,529

-8,936

-7,918

-6,699

-9,230

-10,139

-10,828

-12,019

-12,294

-13,378

-14,747

-15,052

-15,455

-17,301

-16,134

-16,656

-14,932

-11,566

-10,734

-8,930

-8,773

-7,712

-7,034

-5,968

-5,382

-5,905

0

0

0

Net loss per share - basic and diluted

-0.49

-0.51

-0.52

-1.09

-0.79

-0.89

-0.43

-0.64

-0.53

-0.08

-1.09

-1.29

-1.38

-1.35

-0.77

-0.30

-0.31

-0.26

-0.42

-0.42

-0.95

-2.94

-1.11

-0.15

-0.13

0.09

-0.39

-0.37

-0.58

-0.35

-0.40

-0.38

-0.41

-0.88

-0.06

-0.06

-0.06

-0.07

-0.12

Weighted average common shares outstanding - basic and diluted

10,097

10,095

10,095

10,090

10,087

10,088

9,136

7,497

7,497

6,704

3,199

2,423

2,450

-6,628

2,450

6,995

6,982

6,469

6,709

6,709

3,529

-44,814

3,478

27,661

27,584

23,377

14,721

7,991

7,239

5,855

5,762

5,762

5,762

-

23,048

23,048

-

-

-

Weighted average shares outstanding

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

20,955

18,421

15,827